Pluvicto Injection, Solution
Product Images NDC 0078-1217

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pluvicto (NDC 0078-1217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure Of Lutetium (Pluvicto 01)

Chemical structure diagram of lutetium Lu 177 vipivotide tetraxetan, the active ingredient in PLUVICTO injection solution. The molecular structure shows the coordination complex with lutetium at its center, including multiple rings and functional groups.*

FDA Label Image

Figure 1. Kaplan-meier Plot Of Radiographic Progression-free Survival In Psmafore (Pluvicto 02)

A Kaplan-Meier curve depicting radiographic progression-free survival probability (%) over time in months from randomization. It compares two treatment groups: Pluvicto and ARPI, with censoring times marked. A table below shows the number of subjects still at risk at various months for each group.*

FDA Label Image

Figure 2. Kaplan-meier Plot Of Overall Survival In Vision (Pluvicto 03)

A Kaplan-Meier survival curve chart depicting overall survival probability (%) over time in months from randomization for two groups: Pluvicto plus best standard of care (BSoC) and BSoC alone. The graph includes censoring times marked with symbols and a table showing the number of subjects still at risk for each time point.*

FDA Label Image

Principal Display Panel Pluvicto® 1,000 Mbq/ml (27 Mci/ml) Lutetium Lu 177 Vipivotide Tetraxetan Injection Intravenous Use Single-dose Vial Sterile Ndc# 0078-1217-61 Rx Only Novartis (Pluvicto 04)

PLUVICTO 27 mCi/mL (1,000 MBq/mL) lutetium Lu 177 vipivotide tetraxetan injection, solution for intravenous use. Single-dose vial with sterile solution labeled by Novartis Pharmaceuticals Corporation. The label shows storage instructions, radioactive material warning, and space for lot number, vial number, volume, expiration, and activity details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.